These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 35976119)

  • 1. Dofetilide Dose Reductions and Discontinuation in Obese Compared with Nonobese Patients.
    Anderson K; Greenlee K; Matteo M; Wilkoff B
    J Cardiovasc Pharmacol; 2022 Dec; 80(6):820-825. PubMed ID: 35976119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dofetilide-Associated QT Prolongation: Total Body Weight Versus Adjusted or Ideal Body Weight for Dosing.
    Wang SY; Welch TD; Sangha RS; Maloney RW; Cui Z; Kaplan AV
    J Cardiovasc Pharmacol; 2018 Sep; 72(3):161-165. PubMed ID: 29985283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of initial dofetilide dosing recommendation based on actual body weight in overweight and obese patients.
    Cao DX; Kohatsu A; Eng L; Mei K; Dinh J; Mok I; Moreau N; Le A; Shin J
    J Clin Pharm Ther; 2015 Dec; 40(6):635-9. PubMed ID: 26365492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dofetilide dose reductions and discontinuations in women compared with men.
    Pokorney SD; Yen DC; Campbell KB; Allen LaPointe NM; Sheng S; Thomas L; Bahnson TD; Daubert JP; Picini JP; Jackson KP; Thomas KL; Al-Khatib SM
    Heart Rhythm; 2018 Apr; 15(4):478-484. PubMed ID: 29605013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dofetilide dose calculation errors in elderly associated with use of the modification of diet in renal disease equation.
    Denetclaw TH; Oshima N; Dowling TC
    Ann Pharmacother; 2011 Jul; 45(7-8):e44. PubMed ID: 21712508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of bivalirudin dosing strategies using total, adjusted, and ideal body weights in obese patients with heparin-induced thrombocytopenia.
    Tsu LV; Dager WE
    Pharmacotherapy; 2012 Jan; 32(1):20-6. PubMed ID: 22392825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An analysis of measured and estimated creatinine clearance rates in normal weight, overweight, and obese patients with gynecologic cancers.
    Nelson WK; Formica RN; Cooper DL; Schwartz PE; Rutherford TJ
    J Oncol Pharm Pract; 2012 Sep; 18(3):323-32. PubMed ID: 22331238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carboplatin dose calculation in lung cancer patients with low serum creatinine concentrations using CKD-EPI and Cockcroft-Gault with different weight descriptors.
    Kaag D
    Lung Cancer; 2013 Jan; 79(1):54-8. PubMed ID: 23131495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Creatinine-clearance estimates for predicting gentamicin pharmacokinetic values in obese patients.
    Leader WG; Tsubaki T; Chandler MH
    Am J Hosp Pharm; 1994 Sep; 51(17):2125-30. PubMed ID: 7985687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Dose-Adjusted Melphalan in Obese Patients Undergoing Autologous Stem Cell Transplantation.
    Shultes KC; Arp C; Stockerl-Goldstein K; Trinkaus K; DeFrates S
    Biol Blood Marrow Transplant; 2018 Apr; 24(4):687-693. PubMed ID: 29225163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional range of creatinine clearance for renal drug dosing: a practical solution to the controversy of which weight to use in the Cockcroft-Gault equation.
    Brown DL; Masselink AJ; Lalla CD
    Ann Pharmacother; 2013; 47(7-8):1039-44. PubMed ID: 23757387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population Pharmacokinetics and Pharmacodynamics of Meropenem in Nonobese, Obese, and Morbidly Obese Patients.
    Chung EK; Cheatham SC; Fleming MR; Healy DP; Kays MB
    J Clin Pharmacol; 2017 Mar; 57(3):356-368. PubMed ID: 27530916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating prediction methods for glomerular filtration to optimise drug doses in obese and nonobese patients.
    Busse D; Borghardt JM; Petroff D; Pevzner A; Dorn C; El-Najjar N; Huisinga W; Wrigge H; Simon P; Kloft C
    Br J Clin Pharmacol; 2022 Jun; 88(6):2973-2981. PubMed ID: 34688225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Sotalol and Dofetilide Dosing at a Large Academic Medical Center.
    Ting C; Malloy R; Knowles D
    J Cardiovasc Pharmacol Ther; 2020 Sep; 25(5):438-443. PubMed ID: 32347108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of various body weights and serum creatinine concentrations on the bias and accuracy of the Cockcroft-Gault equation.
    Winter MA; Guhr KN; Berg GM
    Pharmacotherapy; 2012 Jul; 32(7):604-12. PubMed ID: 22576791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LEVOTHYROXINE REPLACEMENT IN OBESE HYPOTHYROID FEMALES AFTER TOTAL THYROIDECTOMY.
    Glymph K; Gosmanov AR
    Endocr Pract; 2016 Jan; 22(1):22-9. PubMed ID: 26437220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Intravenous Phenytoin and Fosphenytoin Loading Doses: Influence of Obesity and Sex.
    DasGupta R; Alaniz C; Burghardt D
    Ann Pharmacother; 2019 May; 53(5):458-463. PubMed ID: 30522345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of Oral Dofetilide Reloading for Treatment of Atrial Arrhythmias.
    Cho JH; Youn SJ; Moore JC; Kyriakakis R; Vekstein C; Militello M; Poe SM; Wolski K; Tchou PJ; Varma N; Niebauer MJ; Bhargava M; Saliba WI; Wazni OM; Lindsay BD; Wilkoff BL; Chung MK
    Circ Arrhythm Electrophysiol; 2017 Oct; 10(10):. PubMed ID: 29038104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher Maximum Doses and Infusion Rates Compared with Standard Unfractionated Heparin Therapy Are Associated with Adequate Anticoagulation without Increased Bleeding in Both Obese and Nonobese Patients with Cardiovascular Indications.
    Floroff CK; Palm NM; Steinberg DH; Powers ER; Wiggins BS
    Pharmacotherapy; 2017 Apr; 37(4):393-400. PubMed ID: 28107569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of an Unfractionated Heparin Pharmacy Dosing Protocol for the Treatment of Venous Thromboembolism in Nonobese, Obese, and Severely Obese Patients.
    Hosch LM; Breedlove EY; Scono LE; Knoderer CA
    Ann Pharmacother; 2017 Sep; 51(9):768-773. PubMed ID: 28511582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.